Methyl (1R,4R,5R)-4-methyl-7-oxo-2,3,5-triphenylbicyclo[2.2.1]hept-2-ene-1-carboxylate
C28H24O3 — CID 15372333
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl (1R,4R,5R)-4-methyl-7-oxo-2,3,5-triphenylbicyclo[2.2.1]hept-2-ene-1-carboxylate
Methyl (1R,4R,5R)-4-methyl-7-oxo-2,3,5-triphenylbicyclo[2.2.1]hept-2-ene-1-carboxylate (PubChem CID 15372333) has the molecular formula C28H24O3 and a molecular weight of 408.50 g/mol. Its IUPAC name is methyl (1R,4R,5R)-4-methyl-7-oxo-2,3,5-triphenylbicyclo[2.2.1]hept-2-ene-1-carboxylate.
Molecular Properties
| Compound Name | Methyl (1R,4R,5R)-4-methyl-7-oxo-2,3,5-triphenylbicyclo[2.2.1]hept-2-ene-1-carboxylate |
|---|---|
| PubChem CID | 15372333 |
| Molecular Formula | C28H24O3 |
| Molecular Weight | 408.50 g/mol |
| Exact Mass | 408.17 |
| IUPAC Name | methyl (1R,4R,5R)-4-methyl-7-oxo-2,3,5-triphenylbicyclo[2.2.1]hept-2-ene-1-carboxylate |
| SMILES | COC(=O)[C@@]12C[C@H](c3ccccc3)[C@@](C)(C1=O)C(c1ccccc1)=C2c1ccccc1 |
| InChI | InChI=1S/C28H24O3/c1-27-22(19-12-6-3-7-13-19)18-28(25(27)29,26(30)31-2)24(21-16-10-5-11-17-21)23(27)20-14-8-4-9-15-20/h3-17,22H,18H2,1-2H3/t22-,27-,28-/m1/s1 |
| InChIKey | YVZFZCHGDPVFMH-MWVDVNALSA-N |
| XLogP | 5.53 |
| TPSA | 43.37 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 408.50 |
| LogP ≤ 5 | 5.53 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}, {'alert_name': 'stilbene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 15372333 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.